Oncomine Dx Express Test— 510(k) K260827
Substantially EquivalentLife Technologies Corporation
FDA 510(k) clearance K260827 for Oncomine Dx Express Test, Substantially Equivalent on 2026-10-15. Applicant: Life Technologies Corporation. Device class: 2.
Clearance details
- Applicant
- Life Technologies Corporation
- Product code
- Product code SBY
- Device class
- Class 2
- Regulation
- 21 CFR 866.6085
- Advisory panel
- Pathology
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Traditional
- Location
- Frederick, MD, US
Recent devices under product code SBY
view allMore clearances from Life Technologies Corporation
view all- K241806 — Applied Biosystems TaqPath COVID-19, Flu A, Flu B, RSV Select Panel
- K233453 — Applied Biosystems TaqPath COVID-19 Diagnostic PCR Kit
- K191030 — Applied Biosystems 3500 Dx Genetic Analyzer and Applied Biosystems 3500xL Dx Genetic Analyzer
- K170299 — Ion PGM Dx System
- K123955 — QUANTSTUDIO DX REAL-TIME PCR INSTRUMENT
Data sourced from openFDA. This site is unofficial and independent of the FDA.